Viridian Therapeutics, Inc.\DE (VRDN) Receivables - Other (2016 - 2025)
Viridian Therapeutics, Inc.\DE (VRDN) has 8 years of Receivables - Other data on record, last reported at $70.0 million in Q3 2025.
- For Q3 2025, Receivables - Other rose 499900.0% year-over-year to $70.0 million; the TTM value through Sep 2025 reached $70.0 million, up 499900.0%, while the annual FY2023 figure was $102000.0, 0.0% changed from the prior year.
- Receivables - Other reached $70.0 million in Q3 2025 per VRDN's latest filing, up from $14000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $70.0 million in Q3 2025 and bottomed at $14000.0 in Q3 2024.
- Average Receivables - Other over 5 years is $5.6 million, with a median of $128000.0 recorded in 2023.
- Peak YoY movement for Receivables - Other: crashed 86.27% in 2024, then soared 499900.0% in 2025.
- A 5-year view of Receivables - Other shows it stood at $451000.0 in 2021, then crashed by 77.38% to $102000.0 in 2022, then changed by 0.0% to $102000.0 in 2023, then plummeted by 86.27% to $14000.0 in 2024, then skyrocketed by 499900.0% to $70.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Other were $70.0 million in Q3 2025, $14000.0 in Q3 2024, and $102000.0 in Q1 2024.